-
A Multimodal iPSC Platform for Cystic Fibrosis Drug Testing
2026-05-29
This study introduces a robust induced pluripotent stem cell (iPSC)-derived airway epithelial model for stratifying cystic fibrosis (CF) mutations and testing candidate therapeutics. By combining 3D spheroid and planar culture systems, the platform enables precise, genotype-specific assessment of CFTR function and response to modulators, offering an advanced tool for preclinical research and rare variant drug development.
-
DNA/RNA Heteroduplex and Asparagine Depletion in FGFR2 Fusio
2026-05-29
This study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) that specifically targets FGFR2 fusion genes in intrahepatic cholangiocarcinoma (ICC) and demonstrates enhanced efficacy when combined with asparagine depletion. The findings offer mechanistic insights into tumor adaptation and suggest a promising therapeutic strategy for FGFR2 fusion-driven ICC.
-
Necrostatin-1 in Inflammatory Disease Models: Beyond Necropt
2026-05-28
Explore how Necrostatin-1, a potent RIP1 kinase inhibitor, advances research into necroptosis and inflammation, with new insights into translational disease modeling. This article uniquely connects RIP1 inhibition to gut-microbiota-driven pathologies and emerging assay strategies.
-
Dlin-MC3-DMA: Ionizable Cationic Liposome for RNA Delivery
2026-05-28
Dlin-MC3-DMA has revolutionized RNA therapeutics with its exceptional potency and low toxicity as an ionizable cationic liposome. Its integration into LNPs has advanced gene silencing, mRNA vaccine formulation, and immunomodulation, now further empowered by machine learning-guided design.
-
Sodium Ascorbate (SKU B1834): Reliable Solutions in Cell Ass
2026-05-27
This article examines real-world laboratory scenarios in cell viability and cancer research, focusing on how Sodium Ascorbate (SKU B1834) from APExBIO addresses key challenges such as reproducibility and selective cytotoxicity. Backed by peer-reviewed data and practical workflow guidance, it empowers biomedical researchers to optimize ROS induction and proliferation assays using validated protocols.
-
Applied Workflows for 5-Aminolevulinic acid HCl in Heme Bios
2026-05-27
Explore how 5-Aminolevulinic acid HCl, a high-purity heme pathway intermediate from APExBIO, enables precision research into bacterial virulence and immune evasion. This guide delivers protocol enhancements, troubleshooting strategies, and actionable insights drawn from cutting-edge Salmonella research.
-
FITC-Concanavalin A (ConA) Conjugate: Technical Usage Guide
2026-05-26
FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting immunofluorescence and flow cytometry workflows in glycobiology. It is not suitable for non-carbohydrate targets or applications outside defined storage and handling parameters. Proper protocol adherence is required for consistent results.
-
PD98059: Mechanistic Insights and Advanced Applications in C
2026-05-26
Explore the mechanistic depth of PD98059, a leading MEK inhibitor, in regulating cell fate decisions. This article reveals unique insights into apoptosis induction, cell cycle arrest, and neuroprotection, grounded in primary research and practical assay implications.
-
3-Methyladenine in Applied Autophagy & Cancer Research Workf
2026-05-25
3-Methyladenine (3-MA) empowers researchers to dissect autophagy and PI3K signaling with high specificity, enabling advanced cancer studies and migration assays. This guide delivers actionable workflows, practical troubleshooting, and a translation of recent discoveries—positioning APExBIO’s 3-MA as a cornerstone reagent for reproducible, quantitative autophagy inhibition.
-
Fosinopril Sodium: Mechanistic Insight and Translational Str
2026-05-25
This article delivers a thought-leadership perspective on Fosinopril sodium, a third-generation ACE inhibitor, emphasizing its molecular mechanism, experimental validation, and strategic deployment in translational cardiovascular research. By integrating mechanistic understanding with practical guidance, it offers a roadmap for harnessing Fosinopril sodium as a powerful, evidence-backed tool in hypertension research and cardiovascular disease modeling, while carefully distinguishing its focus from conventional product summaries.
-
Ricin-Induced Necroptosis and Bystander Death in Lung Epithe
2026-05-24
Kempen et al. reveal that ricin toxin exposure in monocytic cells triggers bystander necroptosis in lung epithelial cells via the release of FasL and HMGB1, challenging the prevailing focus on caspase-dependent apoptosis. These findings refine our understanding of inflammatory cell death mechanisms in toxin-mediated lung injury and highlight new experimental considerations for dissecting cell death pathways.
-
Sulfo-NHS-SS-Biotin: Cleavable Biotinylation for Protein Pur
2026-05-23
Sulfo-NHS-SS-Biotin is a water-soluble, amine-reactive biotin disulfide N-hydroxysulfosuccinimide ester enabling reversible protein labeling for affinity purification. Its unique disulfide bond allows label removal with reducing agents, supporting dynamic studies of cell surface proteins and protein trafficking.
-
Substance P: Next-Gen Fluorescence Applications in Bioaeroso
2026-05-22
Explore the emerging role of Substance P, a key tachykinin neuropeptide, in advanced fluorescence-based bioaerosol analysis. This article uncovers unique cross-domain applications and technical workflows distinct from standard pain and inflammation research.
-
Chloroquine (BA1002): Technical Guidance for Research Use
2026-05-22
Chloroquine (SKU BA1002) addresses the need for a robust autophagy inhibitor and immune modulation tool in malaria, cancer, and autoimmune disease research. This compound should not be used where water solubility or non-cytotoxic profiles are required, and careful protocol adherence is essential for reproducibility and safety.
-
FITC-Concanavalin A (ConA) Conjugate: Technical Application
2026-05-21
FITC-Concanavalin A (ConA) Conjugate provides a direct, fluorescence-based method for detecting α-D-glucose and α-D-mannose residues on cell surfaces in immunofluorescence and flow cytometry workflows. It is not suitable for non-carbohydrate targets or protocols outside its defined storage and stability parameters. Use is strictly limited to carbohydrate-binding applications within the reagent's validated scope.